Pathogenesis of Sjögren's syndrome: what we know and what we should learn
- PMID: 22326205
- DOI: 10.1016/j.jaut.2012.01.002
Pathogenesis of Sjögren's syndrome: what we know and what we should learn
Abstract
Sjögren's syndrome (SS) or autoimmune epithelitis is a prototype autoimmune disorder with unique features: a broad clinical spectrum that extends from local exocrinopathy to systemic disease and lymphoma development, and an easy access to the inflamed tissues (minor salivary glands; MSG), which enables the investigators to study the autoimmune processes. The autoimmune lesion consists of lymphocytic infiltrates that develop around the ducts and vary in severity and composition. T cells (mainly CD4(+)) are the dominant lymphocytes in mild MSG lesions, whereas B cells in severe ones. Th1 cytokines predominate in SS infiltrates, albeit Th2 and Th17 responses have been also reported. Notably, increased infiltration by IL-18(+) cells has been associated with parotid gland enlargement and C4-hypocomplementemia, which are adverse prognostic factors for lymphoma development. Even though SS pathogenesis has not been fully revealed, several aspects have been delineated. Among them, the key role of MSG epithelia in the initiation and perpetuation of local autoimmune responses is well-established and involves the capacity of epithelial cells to mediate the recruitment, homing, activation, proliferation and differentiation of immunocytes. In addition, genetic features, including certain HLA phenotypes and polymorphisms in genes encoding cytokines or factors implicated in cytokine signaling, environmental (such as viruses) and hormonal factors are thought to participate in disease pathogenesis. Herein, the known aspects of SS pathogenesis, as well as unmet issues are discussed.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors.Am J Pathol. 2008 Nov;173(5):1389-96. doi: 10.2353/ajpath.2008.080246. Epub 2008 Sep 25. Am J Pathol. 2008. PMID: 18818377 Free PMC article.
-
Characteristics of the minor salivary gland infiltrates in Sjögren's syndrome.J Autoimmun. 2010 Jun;34(4):400-7. doi: 10.1016/j.jaut.2009.10.004. Epub 2009 Nov 3. J Autoimmun. 2010. PMID: 19889514
-
Insight into pathogenesis of Sjögren's syndrome: Dissection on autoimmune infiltrates and epithelial cells.Clin Immunol. 2017 Sep;182:30-40. doi: 10.1016/j.clim.2017.03.007. Epub 2017 Mar 19. Clin Immunol. 2017. PMID: 28330683 Review.
-
[Immunohistochemical study of inflammatory infiltrates in minor salivary glands in Sjögren's syndrome and other autoimmune diseases].Med Clin (Barc). 1998 Nov 28;111(18):681-6. Med Clin (Barc). 1998. PMID: 9887430 Spanish.
-
The role of intrinsic epithelial activation in the pathogenesis of Sjögren's syndrome.J Autoimmun. 2010 Nov;35(3):219-24. doi: 10.1016/j.jaut.2010.06.011. Epub 2010 Aug 4. J Autoimmun. 2010. PMID: 20685080 Review.
Cited by
-
Chemokines and lymphocyte homing in Sjögren's syndrome.Front Immunol. 2024 Apr 26;15:1345381. doi: 10.3389/fimmu.2024.1345381. eCollection 2024. Front Immunol. 2024. PMID: 38736890 Free PMC article. Review.
-
14-3-3η Proteins as a Diagnostic Marker, Disease Activation Indicator, and Lymphoma Predictor in Patients with Primary Sjögren Syndrome.Arch Iran Med. 2023 Oct 1;26(10):582-591. doi: 10.34172/aim.2023.85. Arch Iran Med. 2023. PMID: 38310415 Free PMC article.
-
Characterisation of macrophage infiltration and polarisation based on integrated transcriptomic and histological analyses in Primary Sjögren's syndrome.Front Immunol. 2023 Nov 3;14:1292146. doi: 10.3389/fimmu.2023.1292146. eCollection 2023. Front Immunol. 2023. PMID: 38022546 Free PMC article.
-
Elevated plasma levels of specific antiplatelet glycoprotein autoantibodies in patients with primary Sjögren syndrome with thrombocytopenia.Clin Rheumatol. 2024 Jan;43(1):307-314. doi: 10.1007/s10067-023-06818-y. Epub 2023 Nov 24. Clin Rheumatol. 2024. PMID: 37999855
-
Autoimmune Inflammatory Eye Disease: Demystifying Clinical Presentations for the Internist.Curr Allergy Asthma Rep. 2023 Aug;23(8):471-479. doi: 10.1007/s11882-023-01088-9. Epub 2023 Jul 12. Curr Allergy Asthma Rep. 2023. PMID: 37436637 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous